Drugs / B-type natriuretic peptide
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT01375153 Comparator | Nov 2010 → Mar 2011 | — | Medical University of Vienna | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | B-type natriuretic peptide | “Chronic heart failure is accompanied by anorexia and increased release of B-type natriuretic peptide (BNP) from ventricular cardiomyocytes.” PMID 22698919 ↗ Jun 2012 |
| Known as | BNP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01375153 ↗ |
| Action | Inhibit | “BNP inhibited the fasting-induced increase in total and acylated ghrelin concentrations over time” PMID 22698919 ↗ Jun 2012 |
| Modality | Peptide | “B-type natriuretic peptide (BNP)” NCT01375153 ↗ |
| Route | Intravenous | “continuous intravenous infusion” NCT01375153 ↗ |